These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 15288319
1. Azithromycin versus comparative therapy for the treatment of community acquired pneumonia. Rahav G, Fidel J, Gibor Y, Shapiro M. Int J Antimicrob Agents; 2004 Aug; 24(2):181-4. PubMed ID: 15288319 [Abstract] [Full Text] [Related]
2. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children. Kogan R, Martínez MA, Rubilar L, Payá E, Quevedo I, Puppo H, Girardi G, Castro-Rodriguez JA. Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069 [Abstract] [Full Text] [Related]
3. Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia? Sánchez F, Mensa J, Martínez JA, García E, Marco F, González J, Marcos MA, Soriano A, Torres A. Clin Infect Dis; 2003 May 15; 36(10):1239-45. PubMed ID: 12746768 [Abstract] [Full Text] [Related]
4. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study. File TM, Mandell LA, Tillotson G, Kostov K, Georgiev O. J Antimicrob Chemother; 2007 Jul 15; 60(1):112-20. PubMed ID: 17537866 [Abstract] [Full Text] [Related]
5. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital. Feldman RB, Rhew DC, Wong JY, Charles RA, Goetz MB, American Thoracic Society. Arch Intern Med; 2003 Jul 28; 163(14):1718-26. PubMed ID: 12885688 [Abstract] [Full Text] [Related]
6. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization. Plouffe JF, Breiman RF, Fields BS, Herbert M, Inverso J, Knirsch C, Kolokathis A, Marrie TJ, Nicolle L, Schwartz DB. Clin Infect Dis; 2003 Dec 01; 37(11):1475-80. PubMed ID: 14614670 [Abstract] [Full Text] [Related]
7. Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy. Katz E, Larsen LS, Fogarty CM, Hamed K, Song J, Choudhri S. J Emerg Med; 2004 Nov 01; 27(4):395-405. PubMed ID: 15498622 [Abstract] [Full Text] [Related]
8. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA. Clin Ther; 2008 Feb 01; 30(2):358-71. PubMed ID: 18343274 [Abstract] [Full Text] [Related]
9. A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial. Samsa GP, Matchar DB, Harnett J, Wilson J. Chest; 2005 Nov 01; 128(5):3246-54. PubMed ID: 16304269 [Abstract] [Full Text] [Related]
10. Azithromycin extended-release (Zmax) for sinusitis and pneumonia. Obstet Gynecol; 2006 Jan 01; 107(1):180-2. PubMed ID: 16394059 [No Abstract] [Full Text] [Related]
11. Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting. Malcolm C, Marrie TJ. Arch Intern Med; 2003 Apr 14; 163(7):797-802. PubMed ID: 12695270 [Abstract] [Full Text] [Related]
12. [Uncomplicated community-acquired pneumonia. Under control in 3 treatment days]. MMW Fortschr Med; 2003 Jan 23; 145(3-4):58. PubMed ID: 12619240 [No Abstract] [Full Text] [Related]
13. [Treatment of pneumonia caused by Legionella with azithromycin]. Sánchez F, Mensa J, Martínez JA, Badia R, Albarracín M, Losa JE, Ruiz M, Marcos MA, Torres A, Soriano E. Rev Esp Quimioter; 1998 Jun 23; 11(2):147-51. PubMed ID: 9795300 [Abstract] [Full Text] [Related]
14. [Diagnosis and ambulatory treatment of patients with community-acquired pneumonia: variability of complementary tests and study of the effectiveness of roxithromycin. Study Group on Ambulatory Treatment of Community-Acquired Pneumonia (NACTA)]. Rev Clin Esp; 1999 Nov 23; 199(11):700-4. PubMed ID: 10638232 [Abstract] [Full Text] [Related]
15. An Italian experience of sequential intravenous and oral azithromycin plus intravenous ampicillin/sulbactam in hospitalized patients with community-acquired pneumonia. Todisco T, Dal Farra F, Ciliberti G, Pirina P, Guelfi R, Serra G, Paris R, Mancuso I, Cepparulo M. J Chemother; 2008 Apr 23; 20(2):225-32. PubMed ID: 18467250 [Abstract] [Full Text] [Related]
16. Clinical efficacy and safety of a short regimen of azithromycin sequential therapy vs standard cefuroxime sequential therapy in the treatment of community-acquired pneumonia: an international, randomized, open-label study. Kuzman I, Daković-Rode O, Oremus M, Banaszak AM. J Chemother; 2005 Dec 23; 17(6):636-42. PubMed ID: 16433194 [Abstract] [Full Text] [Related]
17. Experience with levofloxacin in a critical pathway for the treatment of community-acquired pneumonia. Marrie TJ. Chemotherapy; 2004 Dec 23; 50 Suppl 1():11-5. PubMed ID: 15319549 [Abstract] [Full Text] [Related]
18. Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia. File TM, Milkovich G, Tennenberg AM, Xiang JX, Khashab MM, Zadeikis N. Curr Med Res Opin; 2004 Sep 23; 20(9):1473-81. PubMed ID: 15383197 [Abstract] [Full Text] [Related]
19. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia. Lee RW, Lindstrom ST. Respirology; 2007 Jan 23; 12(1):111-6. PubMed ID: 17207035 [Abstract] [Full Text] [Related]
20. Does sputum culture affect the management and/or outcome of community-acquired pneumonia? Shariatzadeh MR, Marrie TJ. East Mediterr Health J; 2009 Jan 23; 15(4):792-9. PubMed ID: 20187530 [Abstract] [Full Text] [Related] Page: [Next] [New Search]